Crossmark

Efficacy and safety of teclistamab in relapsed or refractory multiple myeloma: a systematic review and meta-analysis

Published Online: 2024-11-08

Published Print: 2024-12

Authors

Qureshi, Zaheer

Jamil, Abdur

Altaf, Faryal

Siddique, Rimsha

Ahmed, Faizan
License Information

Text and Data Mining valid from 2024-11-08

Version of Record valid from 2024-11-08
More Information

Article History

Received: 12 September 2024

Accepted: 25 October 2024

First Online: 8 November 2024

Declarations

:

: The authors declare no competing interests.

Document is current